Last 12 months
Inside the activity.
0 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2021 Filed Mar 2, 2021 21:42 UTC |
SMITH WAYNE TDirector · Executive Chairman
|
Exercise / conversionCommon Stock | 210,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016090 · doc4.xml · nonDerivative · entry 1 SMITH WAYNE T · CIK 0001018660 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,725,041 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2018 and 12/31/2020 (the "2018-2020 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2018-2020 Performance Period, the award vested on March 1, 2021 at 200% of the target number of the performance-based restricted shares originally reported by the reporting person on 3/2/2018. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:43 UTC |
Williams Hubert JamesDirector
|
GrantRestricted Stock Units · Derivative | 19,296 | $8.81 Strike: $0.00 | $169,997.76 |
DisclosureSEC source: 0001209191-21-016096 · doc4.xml · derivative · entry 5 Williams Hubert James · CIK 0001659816 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,296 Underlying: Common Stock · 19,296 shares Expires not disclosed F1 · price: The security converts to common stock on a one-to-one basis. F3 · derivative.exercise_date: The Restricted Stock Units vest in 1/3 increments on the first, second and third anniversary of the date of grant. Based on the Reporting Peron's prior deferral election pursuant to the terms of the award agreement, the Reporting Person will be issued that number of shares of the Common Stock of the Company upon the Reporting Person's cessation as a director or upon a date specified by the Reporting Person. F3 · derivative.expiration_date: The Restricted Stock Units vest in 1/3 increments on the first, second and third anniversary of the date of grant. Based on the Reporting Peron's prior deferral election pursuant to the terms of the award agreement, the Reporting Person will be issued that number of shares of the Common Stock of the Company upon the Reporting Person's cessation as a director or upon a date specified by the Reporting Person. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:43 UTC |
Williams Hubert JamesDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 11,356 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016096 · doc4.xml · derivative · entry 4 Williams Hubert James · CIK 0001659816 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,356 Underlying: Common Stock · 11,356 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The Restricted Stock Units vest in 1/3 increments on the first, second and third anniversary date of the date of grant. Upon vesting, the Reporting Person will be issued that number of shares of the Common Stock of the Company. F2 · derivative.expiration_date: The Restricted Stock Units vest in 1/3 increments on the first, second and third anniversary date of the date of grant. Upon vesting, the Reporting Person will be issued that number of shares of the Common Stock of the Company. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:43 UTC |
Williams Hubert JamesDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 12,372 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016096 · doc4.xml · derivative · entry 3 Williams Hubert James · CIK 0001659816 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,372 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The Restricted Stock Units vest in 1/3 increments on the first, second and third anniversary date of the date of grant. Upon vesting, the Reporting Person will be issued that number of shares of the Common Stock of the Company. F2 · derivative.expiration_date: The Restricted Stock Units vest in 1/3 increments on the first, second and third anniversary date of the date of grant. Upon vesting, the Reporting Person will be issued that number of shares of the Common Stock of the Company. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:43 UTC |
Williams Hubert JamesDirector
|
Exercise / conversionCommon Stock | 11,356 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016096 · doc4.xml · nonDerivative · entry 2 Williams Hubert James · CIK 0001659816 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,812 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The security converts to common stock on a one-to-one basis. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:43 UTC |
Williams Hubert JamesDirector
|
Exercise / conversionCommon Stock | 12,372 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016096 · doc4.xml · nonDerivative · entry 1 Williams Hubert James · CIK 0001659816 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,456 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The security converts to common stock on a one-to-one basis. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:41 UTC |
Simon Lynn TPresident and CMO
|
GrantStock Options (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $8.81 | $0.00 |
DisclosureSEC source: 0001209191-21-016080 · doc4.xml · derivative · entry 6 Simon Lynn T · CIK 0001598823 · President and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2031-02-28 F4 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:41 UTC |
Simon Lynn TPresident and CMO
|
GrantPerformance Based Restricted · Derivative | 80,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016080 · doc4.xml · derivative · entry 5 Simon Lynn T · CIK 0001598823 · President and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires not disclosed F3 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2021-2023 Performance Period. F3 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2021-2023 Performance Period. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:41 UTC |
Simon Lynn TPresident and CMO
|
Exercise / conversionPerformance Based Restricted · Derivative | 35,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016080 · doc4.xml · derivative · entry 4 Simon Lynn T · CIK 0001598823 · President and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 35,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2018 and 12/31/2020 (the "2018-2020 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2018-2020 Performance Period, the award vested on March 1, 2021 at 200% of the target number of the performance-based restricted shares originally reported by the reporting person on 3/2/2018. F1 · derivative.expiration_date: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2018 and 12/31/2020 (the "2018-2020 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2018-2020 Performance Period, the award vested on March 1, 2021 at 200% of the target number of the performance-based restricted shares originally reported by the reporting person on 3/2/2018. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:41 UTC |
Simon Lynn TPresident and CMO
|
Tax withholdingCommon Stock | 39,025 | $8.81 | $343,810.25 |
DisclosureSEC source: 0001209191-21-016080 · doc4.xml · nonDerivative · entry 3 Simon Lynn T · CIK 0001598823 · President and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,427 Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:41 UTC |
Simon Lynn TPresident and CMO
|
GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016080 · doc4.xml · nonDerivative · entry 2 Simon Lynn T · CIK 0001598823 · President and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,452 F2 · price: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:41 UTC |
Simon Lynn TPresident and CMO
|
Exercise / conversionCommon Stock | 70,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016080 · doc4.xml · nonDerivative · entry 1 Simon Lynn T · CIK 0001598823 · President and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,452 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2018 and 12/31/2020 (the "2018-2020 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2018-2020 Performance Period, the award vested on March 1, 2021 at 200% of the target number of the performance-based restricted shares originally reported by the reporting person on 3/2/2018. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:40 UTC |
NORTH JULIA BDirector
|
GrantRestricted Stock Units · Derivative | 19,296 | $8.81 Strike: $0.00 | $169,997.76 |
DisclosureSEC source: 0001209191-21-016073 · doc4.xml · derivative · entry 7 NORTH JULIA B · CIK 0001183380 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,296 Underlying: Common Stock · 19,296 shares Expires not disclosed F1 · price: The security converts to common stock on a one-to-one basis. F2 · derivative.exercise_date: The Restricted Stock Units vest in 1/3 increments on the first, second and third anniversary date of the date of grant. Upon vesting, the Reporting Person will be issued that number of shares of the Common Stock of the Company. F2 · derivative.expiration_date: The Restricted Stock Units vest in 1/3 increments on the first, second and third anniversary date of the date of grant. Upon vesting, the Reporting Person will be issued that number of shares of the Common Stock of the Company. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:40 UTC |
NORTH JULIA BDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 11,494 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016073 · doc4.xml · derivative · entry 6 NORTH JULIA B · CIK 0001183380 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,989 Underlying: Common Stock · 11,494 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The Restricted Stock Units vest in 1/3 increments on the first, second and third anniversary date of the date of grant. Upon vesting, the Reporting Person will be issued that number of shares of the Common Stock of the Company. F2 · derivative.expiration_date: The Restricted Stock Units vest in 1/3 increments on the first, second and third anniversary date of the date of grant. Upon vesting, the Reporting Person will be issued that number of shares of the Common Stock of the Company. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:40 UTC |
NORTH JULIA BDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 11,356 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016073 · doc4.xml · derivative · entry 5 NORTH JULIA B · CIK 0001183380 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,356 Underlying: Common Stock · 11,356 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The Restricted Stock Units vest in 1/3 increments on the first, second and third anniversary date of the date of grant. Upon vesting, the Reporting Person will be issued that number of shares of the Common Stock of the Company. F2 · derivative.expiration_date: The Restricted Stock Units vest in 1/3 increments on the first, second and third anniversary date of the date of grant. Upon vesting, the Reporting Person will be issued that number of shares of the Common Stock of the Company. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:40 UTC |
NORTH JULIA BDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 12,372 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016073 · doc4.xml · derivative · entry 4 NORTH JULIA B · CIK 0001183380 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,372 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The Restricted Stock Units vest in 1/3 increments on the first, second and third anniversary date of the date of grant. Upon vesting, the Reporting Person will be issued that number of shares of the Common Stock of the Company. F2 · derivative.expiration_date: The Restricted Stock Units vest in 1/3 increments on the first, second and third anniversary date of the date of grant. Upon vesting, the Reporting Person will be issued that number of shares of the Common Stock of the Company. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:40 UTC |
NORTH JULIA BDirector
|
Exercise / conversionCommon Stock | 11,494 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016073 · doc4.xml · nonDerivative · entry 3 NORTH JULIA B · CIK 0001183380 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,056 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The security converts to common stock on a one-to-one basis. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:40 UTC |
NORTH JULIA BDirector
|
Exercise / conversionCommon Stock | 11,356 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016073 · doc4.xml · nonDerivative · entry 2 NORTH JULIA B · CIK 0001183380 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,562 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The security converts to common stock on a one-to-one basis. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:40 UTC |
NORTH JULIA BDirector
|
Exercise / conversionCommon Stock | 12,372 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016073 · doc4.xml · nonDerivative · entry 1 NORTH JULIA B · CIK 0001183380 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,206 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The security converts to common stock on a one-to-one basis. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:39 UTC |
Krishnan K RangaDirector
|
GrantRestricted Stock Units · Derivative | 19,296 | $8.81 Strike: $0.00 | $169,997.76 |
DisclosureSEC source: 0001209191-21-016067 · doc4.xml · derivative · entry 5 Krishnan K Ranga · CIK 0001724829 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,296 Underlying: Common Stock · 19,296 shares Expires not disclosed F1 · price: The security converts to common stock on a one-to-one basis. F3 · derivative.exercise_date: The Restricted Stock Units vest in 1/3 increments on the first, second and third anniversary of the date of grant. Based on the Reporting Peron's prior deferral election pursuant to the terms of the award agreement, the Reporting Person will be issued that number of shares of the Common Stock of the Company upon the Reporting Person's cessation as a director or upon a date specified by the Reporting Person. F3 · derivative.expiration_date: The Restricted Stock Units vest in 1/3 increments on the first, second and third anniversary of the date of grant. Based on the Reporting Peron's prior deferral election pursuant to the terms of the award agreement, the Reporting Person will be issued that number of shares of the Common Stock of the Company upon the Reporting Person's cessation as a director or upon a date specified by the Reporting Person. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:39 UTC |
Krishnan K RangaDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 11,356 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016067 · doc4.xml · derivative · entry 4 Krishnan K Ranga · CIK 0001724829 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,356 Underlying: Common Stock · 11,356 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The Restricted Stock Units vest in 1/3 increments on the first, second and third anniversary date of the date of grant. Upon vesting, the Reporting Person will be issued that number of shares of the Common Stock of the Company. F2 · derivative.expiration_date: The Restricted Stock Units vest in 1/3 increments on the first, second and third anniversary date of the date of grant. Upon vesting, the Reporting Person will be issued that number of shares of the Common Stock of the Company. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:39 UTC |
Krishnan K RangaDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 12,372 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016067 · doc4.xml · derivative · entry 3 Krishnan K Ranga · CIK 0001724829 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,372 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The Restricted Stock Units vest in 1/3 increments on the first, second and third anniversary date of the date of grant. Upon vesting, the Reporting Person will be issued that number of shares of the Common Stock of the Company. F2 · derivative.expiration_date: The Restricted Stock Units vest in 1/3 increments on the first, second and third anniversary date of the date of grant. Upon vesting, the Reporting Person will be issued that number of shares of the Common Stock of the Company. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:39 UTC |
Krishnan K RangaDirector
|
Exercise / conversionCommon Stock | 11,356 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016067 · doc4.xml · nonDerivative · entry 2 Krishnan K Ranga · CIK 0001724829 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,830 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The security converts to common stock on a one-to-one basis. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:39 UTC |
Krishnan K RangaDirector
|
Exercise / conversionCommon Stock | 12,372 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016067 · doc4.xml · nonDerivative · entry 1 Krishnan K Ranga · CIK 0001724829 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,474 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The security converts to common stock on a one-to-one basis. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:38 UTC |
Johnson Jason KSVP & CAO
|
GrantStock Options (Right to Buy) · Derivative | 18,000 | $0.00 Strike: $8.81 | $0.00 |
DisclosureSEC source: 0001209191-21-016059 · doc4.xml · derivative · entry 4 Johnson Jason K · CIK 0001798438 · SVP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires 2031-02-28 F3 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:38 UTC |
Johnson Jason KSVP & CAO
|
GrantPerformance Based Restricted · Derivative | 18,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016059 · doc4.xml · derivative · entry 3 Johnson Jason K · CIK 0001798438 · SVP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires not disclosed F2 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2021-2023 Performance Period. F2 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2021-2023 Performance Period. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:38 UTC |
Johnson Jason KSVP & CAO
|
Tax withholdingCommon Stock | 4,209 | $8.81 | $37,081.29 |
DisclosureSEC source: 0001209191-21-016059 · doc4.xml · nonDerivative · entry 2 Johnson Jason K · CIK 0001798438 · SVP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,442 Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:38 UTC |
Johnson Jason KSVP & CAO
|
GrantCommon Stock | 18,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016059 · doc4.xml · nonDerivative · entry 1 Johnson Jason K · CIK 0001798438 · SVP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,651 F1 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:38 UTC |
JENNINGS WILLIAM NORRISDirector
|
GrantRestricted Stock Units · Derivative | 19,296 | $8.81 Strike: $0.00 | $169,997.76 |
DisclosureSEC source: 0001209191-21-016050 · doc4.xml · derivative · entry 5 JENNINGS WILLIAM NORRIS · CIK 0001435225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,296 Underlying: Common Stock · 19,296 shares Expires not disclosed F1 · price: The security converts to common stock on a one-to-one basis. F3 · derivative.exercise_date: The Restricted Stock Units vest in 1/3 increments on the first, second and third anniversary of the date of grant. Based on the Reporting Peron's prior deferral election pursuant to the terms of the award agreement, the Reporting Person will be issued that number of shares of the Common Stock of the Company upon the Reporting Person's cessation as a director or upon a date specified by the Reporting Person. F3 · derivative.expiration_date: The Restricted Stock Units vest in 1/3 increments on the first, second and third anniversary of the date of grant. Based on the Reporting Peron's prior deferral election pursuant to the terms of the award agreement, the Reporting Person will be issued that number of shares of the Common Stock of the Company upon the Reporting Person's cessation as a director or upon a date specified by the Reporting Person. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:38 UTC |
JENNINGS WILLIAM NORRISDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 11,356 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016050 · doc4.xml · derivative · entry 4 JENNINGS WILLIAM NORRIS · CIK 0001435225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,356 Underlying: Common Stock · 11,356 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The Restricted Stock Units vest in 1/3 increments on the first, second and third anniversary date of the date of grant. Upon vesting, the Reporting Person will be issued that number of shares of the Common Stock of the Company. F2 · derivative.expiration_date: The Restricted Stock Units vest in 1/3 increments on the first, second and third anniversary date of the date of grant. Upon vesting, the Reporting Person will be issued that number of shares of the Common Stock of the Company. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:38 UTC |
JENNINGS WILLIAM NORRISDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 12,372 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016050 · doc4.xml · derivative · entry 3 JENNINGS WILLIAM NORRIS · CIK 0001435225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,372 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The Restricted Stock Units vest in 1/3 increments on the first, second and third anniversary date of the date of grant. Upon vesting, the Reporting Person will be issued that number of shares of the Common Stock of the Company. F2 · derivative.expiration_date: The Restricted Stock Units vest in 1/3 increments on the first, second and third anniversary date of the date of grant. Upon vesting, the Reporting Person will be issued that number of shares of the Common Stock of the Company. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:38 UTC |
JENNINGS WILLIAM NORRISDirector
|
Exercise / conversionCommon Stock | 11,356 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016050 · doc4.xml · nonDerivative · entry 2 JENNINGS WILLIAM NORRIS · CIK 0001435225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,112 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The security converts to common stock on a one-to-one basis. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:38 UTC |
JENNINGS WILLIAM NORRISDirector
|
Exercise / conversionCommon Stock | 12,372 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016050 · doc4.xml · nonDerivative · entry 1 JENNINGS WILLIAM NORRIS · CIK 0001435225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,756 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The security converts to common stock on a one-to-one basis. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:36 UTC |
Hingtgen TimDirector · CEO
|
GrantStock Options (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $8.81 | $0.00 |
DisclosureSEC source: 0001209191-21-016027 · doc4.xml · derivative · entry 6 Hingtgen Tim · CIK 0001598637 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2031-02-28 F4 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:36 UTC |
Hingtgen TimDirector · CEO
|
GrantPerformance Based Restricted · Derivative | 200,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016027 · doc4.xml · derivative · entry 5 Hingtgen Tim · CIK 0001598637 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires not disclosed F3 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"), as follows: 40% to a Cumulative Consolidated Adjusted EBITDA Growth target; 40% to a Cumulative Same-Store Net Revenue Growth target; and 20% to a Total Shareholder Return ("TSR") Percentile Rank target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2021-2023 Performance Period. F3 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"), as follows: 40% to a Cumulative Consolidated Adjusted EBITDA Growth target; 40% to a Cumulative Same-Store Net Revenue Growth target; and 20% to a Total Shareholder Return ("TSR") Percentile Rank target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2021-2023 Performance Period. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:36 UTC |
Hingtgen TimDirector · CEO
|
Exercise / conversionPerformance Based Restricted · Derivative | 75,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016027 · doc4.xml · derivative · entry 4 Hingtgen Tim · CIK 0001598637 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 75,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2018 and 12/31/2020 (the "2018-2020 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2018-2020 Performance Period, the award vested on March 1, 2021 at 200% of the target number of the performance-based restricted shares originally reported by the reporting person on 3/2/2018. F1 · derivative.expiration_date: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2018 and 12/31/2020 (the "2018-2020 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2018-2020 Performance Period, the award vested on March 1, 2021 at 200% of the target number of the performance-based restricted shares originally reported by the reporting person on 3/2/2018. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:36 UTC |
Hingtgen TimDirector · CEO
|
GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016027 · doc4.xml · nonDerivative · entry 2 Hingtgen Tim · CIK 0001598637 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 616,131 F2 · price: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:36 UTC |
Hingtgen TimDirector · CEO
|
Exercise / conversionCommon Stock | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016027 · doc4.xml · nonDerivative · entry 1 Hingtgen Tim · CIK 0001598637 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 516,131 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2018 and 12/31/2020 (the "2018-2020 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2018-2020 Performance Period, the award vested on March 1, 2021 at 200% of the target number of the performance-based restricted shares originally reported by the reporting person on 3/2/2018. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:37 UTC |
Hirsch Elizabeth TDirector
|
GrantRestricted Stock Units · Derivative | 19,296 | $8.81 Strike: $0.00 | $169,997.76 |
DisclosureSEC source: 0001209191-21-016036 · doc4.xml · derivative · entry 3 Hirsch Elizabeth T · CIK 0001508503 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,296 Underlying: Common Stock · 19,296 shares Expires not disclosed F1 · price: The security converts to common stock on a one-to-one basis. F2 · derivative.exercise_date: The Restricted Stock Units vest in 1/3 increments on the first, second and third anniversary date of the date of grant. Upon vesting, the Reporting Person will be issued that number of shares of the Common Stock of the Company. F2 · derivative.expiration_date: The Restricted Stock Units vest in 1/3 increments on the first, second and third anniversary date of the date of grant. Upon vesting, the Reporting Person will be issued that number of shares of the Common Stock of the Company. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:37 UTC |
Hirsch Elizabeth TDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 11,356 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016036 · doc4.xml · derivative · entry 2 Hirsch Elizabeth T · CIK 0001508503 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,356 Underlying: Common Stock · 11,356 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The Restricted Stock Units vest in 1/3 increments on the first, second and third anniversary date of the date of grant. Upon vesting, the Reporting Person will be issued that number of shares of the Common Stock of the Company. F2 · derivative.expiration_date: The Restricted Stock Units vest in 1/3 increments on the first, second and third anniversary date of the date of grant. Upon vesting, the Reporting Person will be issued that number of shares of the Common Stock of the Company. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:37 UTC |
Hirsch Elizabeth TDirector
|
Exercise / conversionCommon Stock | 11,356 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016036 · doc4.xml · nonDerivative · entry 1 Hirsch Elizabeth T · CIK 0001508503 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,712 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The security converts to common stock on a one-to-one basis. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:34 UTC |
HAMMONS KEVIN JPresident and CFO
|
GrantStock Options (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $8.81 | $0.00 |
DisclosureSEC source: 0001209191-21-016019 · doc4.xml · derivative · entry 6 HAMMONS KEVIN J · CIK 0001542264 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2031-02-28 F4 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:34 UTC |
HAMMONS KEVIN JPresident and CFO
|
GrantPerformance Based Restricted · Derivative | 150,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016019 · doc4.xml · derivative · entry 5 HAMMONS KEVIN J · CIK 0001542264 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires not disclosed F3 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"), as follows: 40% to a Cumulative Consolidated Adjusted EBITDA Growth target; 40% to a Cumulative Same-Store Net Revenue Growth target; and 20% to a Total Shareholder Return ("TSR") Percentile Rank target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2021-2023 Performance Period. F3 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"), as follows: 40% to a Cumulative Consolidated Adjusted EBITDA Growth target; 40% to a Cumulative Same-Store Net Revenue Growth target; and 20% to a Total Shareholder Return ("TSR") Percentile Rank target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2021-2023 Performance Period. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:34 UTC |
HAMMONS KEVIN JPresident and CFO
|
Exercise / conversionPerformance Based Restricted · Derivative | 18,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016019 · doc4.xml · derivative · entry 4 HAMMONS KEVIN J · CIK 0001542264 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2018 and 12/31/2020 (the "2018-2020 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2018-2020 Performance Period, the award vested on March 1, 2021 at 200% of the target number of the performance-based restricted shares originally reported by the reporting person on 3/2/2018. F1 · derivative.exercise_date: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2018 and 12/31/2020 (the "2018-2020 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2018-2020 Performance Period, the award vested on March 1, 2021 at 200% of the target number of the performance-based restricted shares originally reported by the reporting person on 3/2/2018. F1 · derivative.expiration_date: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2018 and 12/31/2020 (the "2018-2020 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2018-2020 Performance Period, the award vested on March 1, 2021 at 200% of the target number of the performance-based restricted shares originally reported by the reporting person on 3/2/2018. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:34 UTC |
HAMMONS KEVIN JPresident and CFO
|
Tax withholdingCommon Stock | 25,119 | $8.81 | $221,298.39 |
DisclosureSEC source: 0001209191-21-016019 · doc4.xml · nonDerivative · entry 3 HAMMONS KEVIN J · CIK 0001542264 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,953 Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:34 UTC |
HAMMONS KEVIN JPresident and CFO
|
GrantCommon Stock | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016019 · doc4.xml · nonDerivative · entry 2 HAMMONS KEVIN J · CIK 0001542264 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 258,072 F2 · price: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:34 UTC |
HAMMONS KEVIN JPresident and CFO
|
Exercise / conversionCommon Stock | 36,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016019 · doc4.xml · nonDerivative · entry 1 HAMMONS KEVIN J · CIK 0001542264 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,072 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2018 and 12/31/2020 (the "2018-2020 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2018-2020 Performance Period, the award vested on March 1, 2021 at 200% of the target number of the performance-based restricted shares originally reported by the reporting person on 3/2/2018. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:34 UTC |
FRY JOHN ADirector
|
GrantRestricted Stock Units · Derivative | 19,296 | $8.81 Strike: $0.00 | $169,997.76 |
DisclosureSEC source: 0001209191-21-016011 · doc4.xml · derivative · entry 7 FRY JOHN A · CIK 0001255140 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,296 Underlying: Common Stock · 19,296 shares Expires not disclosed F1 · price: The security converts to common stock on a one-to-one basis. F2 · derivative.exercise_date: The Restricted Stock Units vest in 1/3 increments on the first, second and third anniversary date of the date of grant. Upon vesting, the Reporting Person will be issued that number of shares of the Common Stock of the Company. F2 · derivative.expiration_date: The Restricted Stock Units vest in 1/3 increments on the first, second and third anniversary date of the date of grant. Upon vesting, the Reporting Person will be issued that number of shares of the Common Stock of the Company. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:34 UTC |
FRY JOHN ADirector
|
Exercise / conversionRestricted Stock Units · Derivative | 11,494 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016011 · doc4.xml · derivative · entry 6 FRY JOHN A · CIK 0001255140 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,989 Underlying: Common Stock · 11,494 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The Restricted Stock Units vest in 1/3 increments on the first, second and third anniversary date of the date of grant. Upon vesting, the Reporting Person will be issued that number of shares of the Common Stock of the Company. F2 · derivative.expiration_date: The Restricted Stock Units vest in 1/3 increments on the first, second and third anniversary date of the date of grant. Upon vesting, the Reporting Person will be issued that number of shares of the Common Stock of the Company. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:34 UTC |
FRY JOHN ADirector
|
Exercise / conversionRestricted Stock Units · Derivative | 11,356 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016011 · doc4.xml · derivative · entry 5 FRY JOHN A · CIK 0001255140 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,356 Underlying: Common Stock · 11,356 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The Restricted Stock Units vest in 1/3 increments on the first, second and third anniversary date of the date of grant. Upon vesting, the Reporting Person will be issued that number of shares of the Common Stock of the Company. F2 · derivative.expiration_date: The Restricted Stock Units vest in 1/3 increments on the first, second and third anniversary date of the date of grant. Upon vesting, the Reporting Person will be issued that number of shares of the Common Stock of the Company. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.